Endovascular Treatment of Thrombosis and Embolism

  • Ahmet Yigit GoktayEmail author
  • Cagin Senturk
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 906)


Deep venous thrombosis (DVT) is a common disorder with a significant mortality rate. Successful endovascular treatment of acute DVT is most likely to be achieved in patients with recently formed thrombus, (<10–14 days) with acute iliofemoral DVT. Endovascular treatment options include: Catheter-directed thrombolysis (CDT), pharmacomechanical catheter-directed thrombolysis (PCDT), percutaneous aspiration thrombectomy (PAT), vena cava filter protection, venous balloon dilatation and venous stent implantation. Current practice shows strong clinical tendency for the use of PCDT with or without other endovascular methods and an individualized approach for each DVT patient. PMT has not received general acceptance because of the associated risk of PE and damage to venous valves caused by thrombectomy devices. PAT is most commonly used as an adjunctive endovascular technique like balloon maceration to fragment thrombus, balloon angioplasty, stent implantation and vena cava filter placement. Interventional endovascular therapies for DVT have the potential to provide PE protection and prevention of PTS. Patient centered individualized approach for endovascular DVT treatment is recommended to optimize the ideal clinical result.

Acute stroke is the leading cause of death for people above the age of 60 and the fifth leading cause in people aged 15–59. Mortality during the first 30 days of ischemic stroke is 20 % and 30 % of survivors will remain permanently disabled. Acute stroke patients within the therapeutic window must receive IVrtPA unless there is a contraindication. In case of contraindication to IVrtPA or for patients out of the therapeutic window for thrombolytics, standart of care is the intraarterial treatment. Patients have to be transferred to a comprehensive stroke center with capacity of dedicated neurovascular imaging and interventional neuroradiology. Noncontrast head CT that is used to rule out hemorrhage is followed by imaging studies dedicated to show if there is reasonable penumbra to save. Intraarterial thrombolysis has the main advantage of extended therapy window, earlier and more efficient recanalization and less risk of hemorrhage due to lower doses of thrombolytics. Mechanical thrombectomy has several advantages over IV/IA fibrinolysis including faster recanalization and less risk of hemorrhage especially in large artery occlusions. ASA guidelines recommend choosing stent retrievers over other devices for mechanical thrombectomy. Better recanalization rates and less infarct volume after mechanical thrombectomy result in higher numbers of functionally independent patients compared with other treatments. Two landmark studies that were published recently, SWIFT PRIME and MR CLEAN, showed that IA treatment especially with the new stent retrievers lead to a significant increase in functional recovery and independence in daily life after an acute stroke.

Cerebral venous and sinus thrombosis (CVST) comprises nearly 0.5–1 % of all stroke cases. CVST causes different neurological deficits depending on the sinus/cortical vein involved. CVST may cause death and dependency in 13.4 % of patients. CT/CT venography and MR/MR venography can be effectively used to diagnose and to follow up CVT cases. Anticoagulation with heparin is the most widely accepted therapy to prevent the expansion of the thrombus. Patients deteriorating despite heparinization and patients presenting with very severe neurological deficits must receive endovascular treatment. Endovascular methods include intrasinus infusion of thrombolytics or heparin, balloon angioplasty, mechanical thrombectomy or a combination of different techniques. There is a higher rate or recanalization with endovascular methods compared to other medical therapies.


Endovascular Deep venous thrombosis Catheter Thrombolysis Thrombectomy Stroke Stent retrievers Cerebral venous thrombosis 


  1. 1.
    Fowkes FJ, Price JF, Fowkes FG (2003) Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25(1):1–5CrossRefPubMedGoogle Scholar
  2. 2.
    Scarvelis D, Wells PS (2006) Diagnosis and treatment of deep vein thrombosis. CMAJ 175(9):1087–1092CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Geerts W, Ray JG, Colwell CW, Bergqvist D, Pineo G, Lassen MR et al (2005) Prevention of venous thromboembolism. Chest 128(5):3775–3776CrossRefPubMedGoogle Scholar
  4. 4.
    Vedantham S (2012) Interventional approaches to deep vein thrombosis. Am J Hematol 87(Suppl 1):S113–S118CrossRefPubMedGoogle Scholar
  5. 5.
    Pernes JM, Auguste M, Kovarski S, Borie H, Renaudin JM, Coppe G (2012) Diagn Interv Imaging 93(10):725–733CrossRefPubMedGoogle Scholar
  6. 6.
    Elsharawy M, Elzayat E (2002) Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomized clinical trial. Eur J Vasc Endovasc Surg 24(3):209–214CrossRefPubMedGoogle Scholar
  7. 7.
    Rogers LQ, Lutcher CL (1990) Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med 88(4):389–395CrossRefPubMedGoogle Scholar
  8. 8.
    Plate G, Eklof B, Norgren L, Ohlin P, Dahlstrom JA (1997) Venous thrombectomy for iliofemoral vein thrombosis 10 year results of a prospective randomized study. Eur J Vasc Endovasc Surg 14(5):367–374CrossRefPubMedGoogle Scholar
  9. 9.
    Plate G, Einarsson E, Ohlin P, Jensen R, Qvarfordt P, Eklof B (1984) Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1(6):867–876CrossRefPubMedGoogle Scholar
  10. 10.
    Vedantham S, Sista AK, Klein SJ, Nayak L, Razavi MK, Kalva SP, et al. Society of Interventional Radiology and Cardiovascular and Interventional Radiological Society of Europe Standards of Practice Committees (2014) Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 25(9):1317–1325Google Scholar
  11. 11.
    Semba CP, Dake MD (1994) Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 191:487–494CrossRefPubMedGoogle Scholar
  12. 12.
    Mewissen WM, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a National Multicenter Registry. Radiology 211:39–49CrossRefPubMedGoogle Scholar
  13. 13.
    Cakir V, Gulcu A, Akay E, Capar AE, Gencpinar T, Kucuk B et al (2014) Use of percutaneous aspiration thrombectomy vs. anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomized clinical trial. Cardiovasc Intervent Radiol 37:969–976CrossRefPubMedGoogle Scholar
  14. 14.
    Sugimoto K, Hoffman LV, Razavi MK et al (2003) The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter directed thrombolysis of arterial and venous occlusions. J Vasc Surg 37:512–517CrossRefPubMedGoogle Scholar
  15. 15.
    Vedantham S, Vesely TM, Sicard GA et al (2004) Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 15:565–574CrossRefPubMedGoogle Scholar
  16. 16.
    Bush RL, Lin PH, Bates JT et al (2004) Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 40:965–970CrossRefPubMedGoogle Scholar
  17. 17.
    Lin PH, Zhou W, Dardik A et al (2006) Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 192:782–788CrossRefPubMedGoogle Scholar
  18. 18.
    Cynamon J, Stein EG, Dym J et al (2006) A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. J Vasc Interv Radiol 17:1043–1049CrossRefPubMedGoogle Scholar
  19. 19.
    O’Sullivan G, Lohan DG, Gough N et al (2007) Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol 18:715–724CrossRefPubMedGoogle Scholar
  20. 20.
    Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830CrossRefPubMedGoogle Scholar
  21. 21.
    Turmel-Rodrigues L, Raynaud A, Louail B, Beyssen B, Sapoval M (2001) Manual catheter-directed aspiration and other thrombectomy techniques for declotting native fistulas for hemodialysis. J Vasc Interv Radiol 12(12):1365–1371CrossRefPubMedGoogle Scholar
  22. 22.
    Oguzkurt L, Ozkan U, Gulcan O, Koca N, Gur S (2012) Endovascular treatment of acute and subacute iliofemoral deep venous thrombosis by using manual aspiration thrombectomy: long-term results of 139 patients in a single center. Diagn Interv Radiol 18(4):410–416PubMedGoogle Scholar
  23. 23.
    Mackay J, Mensah G, Mendis S, Greenlund K (2004) Atlas of heart disease and stroke. World Health Organization, GenevaGoogle Scholar
  24. 24.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 27;131(4):e29–322. doi: 10.1161/CIR.0000000000000152
  25. 25.
    Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics: 2008 update—a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146CrossRefPubMedGoogle Scholar
  26. 26.
    Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947Google Scholar
  27. 27.
    Christou I, Burgin WS, Alexandrov AV, Grotta JC (2001) Arterial status after intravenous TPA therapy for ischaemic stroke: a need for further interventions. Int Angiol 20:208–213PubMedGoogle Scholar
  28. 28.
    Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21):2003–2011CrossRefPubMedGoogle Scholar
  29. 29.
    Lisboa RC, Jovanovic BD, Alberts MJ (2002) Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 33(12):2866–2871CrossRefPubMedGoogle Scholar
  30. 30.
    IMS Study Investigators (2004) Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35:904–911CrossRefGoogle Scholar
  31. 31.
    Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Interventional Management of Stroke (IMS) III Investigators (2013) Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 368(10):893–903. doi: 10.1056/NEJMoa1214300
  32. 32.
    Wolpert SM, Bruckmann H, Greenlee R et al (1993) Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: the rtPA Acute Stroke Study Group. AJNR Am J Neuroradiol 14:3–13PubMedGoogle Scholar
  33. 33.
    Nogueira RG, Schwamm LH, Hirsch JA (2009) Endovascular approaches to acute stroke, Part 1: Drugs, devices, and data. AJNR Am J Neuroradiol 30:649–661CrossRefPubMedGoogle Scholar
  34. 34.
    IMS II Trial Investigators (2007) The Interventional Management of Stroke (IMS) II study. Stroke 38:2127–2135CrossRefGoogle Scholar
  35. 35.
    Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC et al (2000) Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 55:1649–1655CrossRefPubMedGoogle Scholar
  36. 36.
    Nogueira RG, Smith WS (2009) Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and Multi MERCI trials. Stroke 40:516–522CrossRefPubMedGoogle Scholar
  37. 37.
    Higashida RT, Furlan AJ, Roberts H et al (2003) Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:e109–e137CrossRefPubMedGoogle Scholar
  38. 38.
    Kallmes DF (2012) TICI: if you are not confused, then you are not paying attention. AJNR Am J Neuroradiol 33:975–976CrossRefPubMedGoogle Scholar
  39. 39.
    Smith WS, Sung G, Starkman S et al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432–1438CrossRefPubMedGoogle Scholar
  40. 40.
    Smith WS, Sung G, Saver J et al (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205–1212CrossRefPubMedGoogle Scholar
  41. 41.
    Bose A, Henkes H, Alfke K et al (2008) The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 29:1409–1413CrossRefPubMedGoogle Scholar
  42. 42.
    Penumbra Pivotal Stroke Trial Investigators (2009) The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8):2761–2768. doi: 10.1161/STROKEAHA.108.544957 CrossRefGoogle Scholar
  43. 43.
    Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG et al. SWIFT Trialists (2012) Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380:1241–1249Google Scholar
  44. 44.
    Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. TREVO 2 Trialists (2012) Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomized trial. Lancet 380:1231–1240Google Scholar
  45. 45.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al. SWIFT PRIME Investigators (2015) Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tpa with IV tpa alone in acute ischemic stroke. Int J Stroke 10(3):439–448. doi:  10.1111/ijs.12459
  46. 46.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM et al. SWIFT PRIME Investigators (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–95. doi: 10.1056/NEJMoa1415061
  47. 47.
    Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al. MR CLEAN Investigators (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11–20. doi: 10.1056/NEJMoa1411587
  48. 48.
    Mehta B, Leslie-Mazwi TM, Chandra RV et al (2013) Assessing variability in neurointerventional practice patterns for acute ischemic stroke. J Neurointerv Surg 5(Suppl 1):i52–i57CrossRefPubMedGoogle Scholar
  49. 49.
    Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791–1798CrossRefPubMedGoogle Scholar
  50. 50.
    Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338(25):1793–1797CrossRefPubMedGoogle Scholar
  51. 51.
    Cantú C, Barinagarrementeria F (1993) Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 24(12):1880–1884CrossRefPubMedGoogle Scholar
  52. 52.
    Rahmanian R, Wan Fook Cheung V, Chadha NK (2015) Non-fatal extensive cerebral venous thrombosis as a complication of adenotonsillectomy. Int J Pediatr Otorhinolaryngol 79(2):254–258. doi: 10.1016/j.ijporl.2014.11.016 CrossRefPubMedGoogle Scholar
  53. 53.
    Emir M, Ozisik K, Cagli K, Bakuy V, Ozisik P, Sener E (2004) Dural sinus thrombosis after cardiopulmonary bypass. Perfusion 19(2):133–135CrossRefPubMedGoogle Scholar
  54. 54.
    Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35(3):664–670CrossRefPubMedGoogle Scholar
  55. 55.
    Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F et al. ISCVT Investigators (2007) Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 38(2):337–342. Epub 2007 Jan 4Google Scholar
  56. 56.
    Linn J, Pfefferkorn T, Ivanicova K, Müller-Schunk S, Hartz S, Wiesmann M et al (2009) Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol 30(4):728–735. doi: 10.3174/ajnr.A1451 CrossRefPubMedGoogle Scholar
  57. 57.
    Bonneville F (2014) Imaging of cerebral venous thrombosis. Diagn Interv Imaging 95(12):1145–1150. doi: 10.1016/j.diii.2014.10.006 CrossRefPubMedGoogle Scholar
  58. 58.
    Bracken J, Barnacle A, Ditchfield M (2013) Potential pitfalls in imaging of paediatric cerebral sinovenous thrombosis. Pediatr Radiol 43(2):219–231. doi: 10.1007/s00247-012-2402-6 CrossRefPubMedGoogle Scholar
  59. 59.
    Linn J, Brückmann H (2010) Cerebral venous and dural sinus thrombosis: state-of-the-art imaging. Clin Neuroradiol 20(1):25–37. doi: 10.1007/s00062-010-9035-7 CrossRefPubMedGoogle Scholar
  60. 60.
    Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F et al (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13:553–559CrossRefPubMedGoogle Scholar
  61. 61.
    Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6:162–170CrossRefPubMedGoogle Scholar
  62. 62.
    Coutinho JM, Ferro JM, Canhaõ P, Barinagarrementeria F, Bousser MG, Stam J, for the ISCVT investigators (2010) Unfractionated or low–molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 41:2575–2580Google Scholar
  63. 63.
    Masuhr F, Mehraein S (2004) Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care 1(3):355–361CrossRefPubMedGoogle Scholar
  64. 64.
    Rahman M, Velat GJ, Hoh BL, Mocco J (2009) Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus 27(5):E7. doi: 10.3171/2009.7.FOCUS09146 CrossRefPubMedGoogle Scholar
  65. 65.
    Rael JR, Orrison WW Jr, Baldwin N, Sell J (1997) Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. AJNR Am J Neuroradiol 18:1238–1242PubMedGoogle Scholar
  66. 66.
    Philips MF, Bagley LJ, Sinson GP, Raps EC, Galetta SL, Zager EL et al (1999) Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 90:65–71CrossRefPubMedGoogle Scholar
  67. 67.
    Chaloupka JC, Mangla S, Huddle DC (1999) Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report. Neurosurgery 45:650–657CrossRefPubMedGoogle Scholar
  68. 68.
    Chow K, Gobin YP, Saver J, Kidwell C, Dong P, Vinuela F (2000) Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 31:1420–1425CrossRefPubMedGoogle Scholar
  69. 69.
    Curtin KR, Shaibani A, Resnick SA, Russell EJ, Simuni T (2004) Rheolytic catheter thrombectomy, balloon angioplasty, and direct recombinant tissue plasminogen activator thrombolysis of dural sinus thrombosis with preexisting hemorrhagic infarctions. AJNR Am J Neuroradiol 25:1807–1811PubMedGoogle Scholar
  70. 70.
    Newman CB, Pakbaz R, Nguyen A, Kerber C (2009) Endovascular treatment of extensive cerebral sinus thrombosis. J Neurosurg 110:442–445CrossRefPubMedGoogle Scholar
  71. 71.
    Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK (1999) Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke 30:489–494CrossRefPubMedGoogle Scholar
  72. 72.
    Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH (2001) Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 32:2310–2317CrossRefPubMedGoogle Scholar
  73. 73.
    Soleau SW, Schmidt R, Stevens S, Osborn A, Macdonald J (2003) Extensive experience with dural sinus thrombosis. Neurosurgery 52:534–544CrossRefPubMedGoogle Scholar
  74. 74.
    Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA (2008) Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 39:1487–1490CrossRefPubMedGoogle Scholar
  75. 75.
    La Barge DV 3rd, Bishop FS, Stevens EA, Eskandari R, Schmidt RH, Skalabrin EJ et al (2009) Intrasinus catheter-directed heparin infusion in the treatment of dural venous sinus thrombosis. AJNR Am J Neuroradiol 30(9):1672–1678. doi: 10.3174/ajnr.A1677 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Interventional RadiologyDokuz Eylul University Medical School HospitalIzmirTurkey
  2. 2.Neurointerventional Radiology Division, Department of Radiological SciencesUniversity of California Irvine, School of MedicineOrangeUSA

Personalised recommendations